oral cavity cancer: A primary or metastatic malignant neoplasm involving the oral cavity. The majority are squamous cell carcinomas.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
129 |
4. Check minimum number of eventsNone |
129 |
5. Include endpointsNone |
129 |
6. Filter based on genotype QC (FinnGen only) |
129 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum basis oris
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Floor of mouth
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Floor of mouth
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1059 | 557 | 490 |
| Only index persons | 897 | 489 | 408 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 53.91 | 54.65 | 52.78 |
| Only index persons | 51.89 | 53.01 | 50.55 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 129 | 70 | 59 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 51.62 | 50.68 | 52.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 115
- Matched controls
- 1150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.2
ICD-10 Finland
Benign neoplasm: Floor of mouth
+∞
124.7
96
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
66.7
26.8
30
6
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
183.7
15.9
16
*
21030
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Floor of mouth
+∞
14.9
14
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
85.2
7.5
8
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
70
404
2.60
6.63
2.6
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
74
487
2.22
4.67
4.7
6.1
%
2.4
2.7
0.70
65
457
(42870588) Differential panel, method unspecified - Blood
57
338
2.23
4.66
3.9
5.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
74
488
2.21
4.63
5.0
6.4
%
8.0
8.4
0.49
67
461
(3018010) Neutrophils/100 leukocytes in Blood
74
494
2.17
4.42
4.6
5.9
%
58.3
58.0
0.05
68
464
(3002030) Lymphocytes/100 leukocytes in Blood
74
500
2.13
4.22
4.7
6.2
%
27.4
27.2
0.04
68
468
(3013115) Eosinophils [#/volume] in Blood
77
536
2.08
3.97
6.1
6.3
e9/l
0.2
0.2
0.00
66
485
(3003458) Phosphate [Moles/volume] in Serum or Plasma
28
131
2.45
3.87
4.9
7.0
mmol/l
1.0
1.0
0.31
23
121
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
62
405
2.02
3.74
2.4
2.3
nmol/l
69.7
75.2
0.84
56
353
(3052851) Hemolysis interference index of Serum or Plasma
11
30
3.92
3.72
4.6
3.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
74
518
2.01
3.64
4.9
6.1
e9/l
0.6
0.6
0.63
63
463
(3006315) Basophils [#/volume] in Blood
74
520
1.99
3.58
5.0
6.2
e9/l
0.0
0.0
0.36
63
464
(3022096) Basophils/100 leukocytes in Blood
69
474
1.98
3.56
4.8
6.0
%
0.7
0.6
0.14
62
442
(3023368) Bacteria identified in Blood by Culture
46
280
2.00
3.30
5.1
4.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
74
530
1.93
3.29
4.9
6.1
e9/l
2.2
1.8
0.55
64
482
(3013650) Neutrophils [#/volume] in Blood by Automated count
81
603
1.92
3.15
9.3
10.3
e9/l
4.4
4.2
0.34
68
538
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
23
4.12
2.83
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
30
167
2.04
2.71
3.0
3.7
ng/l
59.0
179.5
0.80
22
134
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
37
224
1.91
2.63
2.5
2.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
57
406
1.72
2.34
2.0
1.9
pmol/l
86.7
96.6
1.07
34
197
(1002224) Polysomnography panel
11
41
2.84
2.34
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
216
1.85
2.33
1.7
1.7
mg/l
1.1
1.2
0.26
22
173
(3037467) Urinalysis macro (dipstick) panel - Urine
87
709
1.70
2.07
4.7
4.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
26
3.21
2.05
1.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
109
949
1.96
2.05
20.9
14.3
%
41.1
40.6
0.34
73
713
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
32
2.94
2.04
4.0
2.3
mg/l
1.4
1.6
—
9
27
(40758558) Short blood count panel - Blood
40
267
1.72
2.03
7.4
6.6
—
—
—
0
0
(3044889) 12 lead EKG panel
88
722
1.69
2.01
3.9
3.8
—
—
—
0
0
(4035726)
17
85
2.15
2.01
1.8
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
11
45
2.58
1.99
3.5
5.1
mmol/l
25.6
24.0
0.52
11
39
(3044640) Blood type and Crossmatch panel - Blood
45
314
1.67
1.93
2.9
2.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
21
117
1.95
1.88
4.7
4.4
u/l
230.8
248.5
0.40
21
112
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
35
2.69
1.84
1.4
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
35
2.69
1.84
1.4
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
35
2.69
1.84
1.4
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
68
2.19
1.78
1.3
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
24
144
1.82
1.73
2.1
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
60
460
1.57
1.72
8.6
10.3
e9/l
0.0
0.0
0.74
45
383
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
43
2.44
1.65
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
53
399
1.56
1.62
8.5
8.2
inr
1.2
1.2
0.02
19
130
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
90
763
1.59
1.62
4.0
3.9
pmol/l
15.0
14.8
0.27
83
681
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
26
2.79
1.60
2.0
2.2
%
199.7
193.2
—
7
26
(3022145) Colonoscopy Study observation
18
101
1.91
1.58
1.6
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
58
2.18
1.55
1.6
1.7
—
—
—
0
0
(3012544) pH of Venous blood
16
88
1.93
1.49
3.1
4.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
12
59
2.14
1.49
2.5
2.2
ng/l
157.1
231.3
0.42
12
51
(3022948) Iron [Moles/volume] in Serum or Plasma
25
159
1.71
1.49
2.5
2.5
umol/l
13.6
13.4
0.04
25
143
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
28
2.58
1.47
1.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
28
2.58
1.47
1.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
28
2.58
1.47
1.0
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
106
944
1.69
1.46
5.4
4.6
mu/l
1.9
1.9
0.25
97
847
(3013826) Glucose [Moles/volume] in Serum or Plasma
74
609
1.50
1.46
6.5
4.5
mmol/l
6.4
6.7
0.84
68
556
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
16
3.21
1.45
1.8
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
16
3.21
1.45
1.8
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
58
457
1.49
1.40
3.9
4.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
118
1088
1.99
1.38
16.3
13.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
17
3.02
1.37
1.4
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
14
76
1.94
1.36
1.6
2.5
ug/l
3.3
7.5
1.98
14
67
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
43
2.17
1.33
1.9
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
110
997
1.70
1.32
4.2
4.5
mmol/l
6.2
5.9
1.03
96
906
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
25
2.47
1.26
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
15
86
1.84
1.25
3.5
5.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
20
126
1.70
1.23
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
159
1.63
1.23
1.8
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
43
327
1.47
1.21
3.8
3.4
mmol/l
2.4
2.3
0.91
36
284
(3000991) Gas panel - Venous blood
13
73
1.87
1.15
15.3
9.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
112
1029
1.67
1.15
19.9
14.4
mg/l
24.6
21.5
0.48
95
807
(3019309) Folate [Moles/volume] in Red Blood Cells
28
196
1.55
1.15
1.6
1.7
nmol/l
825.0
1210.0
2.09
20
145
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
30
2.41
1.14
2.1
1.7
%
94.9
90.0
—
7
30
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
30
2.41
1.14
2.0
1.3
u/l
5.1
9.6
—
7
24
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
30
2.41
1.14
1.3
1.3
—
4.1
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
59
1.94
1.11
1.4
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
21
2.43
1.10
3.6
2.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
12
67
1.87
1.09
4.0
5.0
ng/l
128.3
86.0
0.52
12
60
(3026782) Osmolality of Urine
30
217
1.50
1.06
3.9
2.7
mosm/kgh2o
460.4
573.4
2.45
30
183
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
157
1.57
1.05
3.7
2.8
e6/l
1.4
2.7
—
10
89
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
22
2.32
1.04
1.0
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
166
1.55
1.04
3.7
2.7
e6/l
0.9
0.7
0.22
11
96
(3007853) Bacteria identified in Skin by Aerobe culture
18
116
1.64
1.03
2.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.99
0.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
28
0.00
0.99
0.0
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
47
377
1.39
0.96
5.4
3.7
e6/l
64.0
60.0
0.04
38
273
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
107
985
1.51
0.95
18.9
13.4
ml/min/173m2
79.8
81.1
0.24
89
785
(40768797) Stomach Pathology biopsy report
21
145
1.54
0.92
1.5
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
38
296
1.40
0.92
4.1
4.4
ph
7.4
7.4
—
9
57
(3000492) Spirometry study
13
79
1.72
0.92
1.6
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
117
1100
1.68
0.92
11.1
10.4
u/l
29.0
26.5
0.43
112
1064
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
15
96
1.64
0.89
2.2
2.6
u/l
46.7
32.5
0.54
15
78
(1761868) Lipid panel - Serum or Plasma
33
418
0.72
0.86
3.0
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
32
245
1.41
0.85
5.1
6.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
73
1.71
0.85
1.2
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
37
292
1.37
0.83
5.1
2.9
e6/l
0.4
0.3
0.11
31
215
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
33
415
0.72
0.82
3.6
4.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
45
367
1.35
0.82
4.8
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
30
229
1.40
0.81
4.2
2.6
e6/l
5.6
4.6
0.34
30
200
(3020564) Creatinine [Moles/volume] in Serum or Plasma
116
1096
1.58
0.78
22.6
16.4
umol/l
78.6
79.4
0.12
116
1096
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
23
168
1.45
0.78
1.2
1.2
u/ml
0.8
6.4
—
5
76
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
34
1.80
0.77
2.7
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
41
333
1.34
0.76
4.9
3.0
e6/l
57.7
227.8
0.42
34
259
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
25
2.04
0.73
1.2
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
36
289
1.34
0.72
5.0
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
38
308
1.33
0.71
3.5
3.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
27
1.89
0.69
1.0
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
28
1.82
0.67
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
28
1.82
0.67
1.0
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
17
121
1.47
0.66
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
111
1048
1.42
0.66
4.8
4.8
mmol/l
2.8
2.7
0.02
100
961
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
49
418
1.28
0.63
3.2
3.8
ng/l
22.8
38.7
0.98
35
287
(3041096) Erythrocytes [Presence] in Urine by Automated
24
305
0.74
0.63
3.8
3.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
30
1.69
0.62
2.0
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
29
231
1.33
0.61
2.5
3.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
20
150
1.39
0.60
4.9
1.8
s
30.2
29.5
0.15
20
143
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
115
1.45
0.60
3.6
4.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
53
1.54
0.59
2.8
2.5
%
0.9
1.3
—
8
53
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
54
1.51
0.58
1.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
73
1.55
0.58
1.5
1.5
—
—
—
0
0
(4010399)
11
73
1.55
0.58
1.5
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
36
1.70
0.57
1.7
1.8
nmol/l
37.3
40.9
—
6
36
(3012516) Albumin [Mass/volume] in Urine
34
280
1.29
0.57
3.5
3.1
mg/l
2280.9
289.1
0.41
21
176
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
53
463
1.25
0.55
9.3
7.7
mmol/l
1.2
1.2
0.24
47
389
(3013512) EKG study
36
302
1.27
0.52
4.5
3.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
40
1.52
0.52
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
40
1.52
0.52
1.2
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
14
101
1.43
0.52
3.6
1.9
nmol/l
387.4
351.1
0.44
14
88
(3004588) Protein electrophoresis panel - Serum or Plasma
9
65
1.41
0.52
1.7
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
18
231
0.74
0.50
3.1
4.2
kg/l
1.0
1.0
—
5
24
(3029937) Albumin [Presence] in Urine by Test strip
24
295
0.77
0.50
3.4
4.2
estimate
0.0
0.0
—
10
107
(3026493) Urate [Moles/volume] in Serum or Plasma
34
286
1.26
0.48
3.5
2.9
umol/l
351.3
8652.8
1.50
28
242
(3001019) Free T4 and TSH panel - Serum or Plasma
7
50
1.42
0.46
2.6
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
113
1.37
0.45
1.9
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
16
123
1.34
0.43
4.9
4.3
%
26.1
30.4
—
10
75
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
58
1.40
0.42
25.0
5.1
mmol/l
24.8
24.9
—
8
58
(3020682) Albumin/Creatinine [Ratio] in Urine
35
300
1.23
0.42
4.3
3.9
mg/mmol
13.3
8.6
0.36
23
190
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
101
959
1.25
0.42
5.4
5.7
mmol/mol
41.3
40.1
0.48
93
892
(3023511) Choriogonadotropin [Units/volume] in Urine
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.2
—
58.8
—
0
16
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
124
1.33
0.41
1.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
66
1.39
0.39
2.8
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
36
1.40
0.38
1.2
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
41
1.49
0.36
3.0
2.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
77
719
1.18
0.36
2.7
3.0
u/l
45.3
51.4
0.40
70
673
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
107
1028
1.24
0.35
4.1
4.4
mmol/l
4.7
4.7
0.14
97
950
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
45
1.35
0.34
1.5
3.6
mmol/l
23.3
24.3
—
6
45
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
46
1.32
0.33
1.3
2.1
u/l
44.8
42.6
—
6
41
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
6
46
1.32
0.33
1.3
2.1
g/l
1.4
1.6
—
6
36
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
147
1.26
0.33
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
40
358
1.17
0.31
5.0
4.5
ug/l
2.2
2.0
0.23
33
319
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
64
1.27
0.28
1.3
1.2
—
33.9
—
0
5
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
72
677
1.14
0.28
2.8
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
104
1.28
0.27
1.4
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
179
1.21
0.27
1.3
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
77
1.32
0.27
1.4
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
114
1.26
0.26
2.1
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
115
1.24
0.24
12.2
7.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
102
988
1.15
0.22
3.9
3.9
mmol/l
1.4
1.3
0.90
88
897
(4268621)
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
4.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
1.8
—
0.2
—
0
5
(4281824)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
0
13
0.00
0.21
0.0
8.0
—
7.4
—
0
5
(3021601) Nitrite [Presence] in Urine by Test strip
49
524
0.90
0.20
5.1
5.3
estimate
0.0
0.0
0.00
11
111
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
50
1.21
0.20
2.3
2.7
—
—
—
0
0
(3015736) pH of Urine
44
410
1.11
0.18
2.6
3.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
81
779
1.11
0.18
4.1
4.1
mm/h
11.9
11.9
0.02
75
709
(40761535) Cells panel - Urine sediment
8
69
1.17
0.17
2.0
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
50
529
0.91
0.16
3.4
3.9
estimate
0.0
0.0
0.00
11
108
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
9
82
1.10
0.15
2.8
5.2
mmol/l
1.2
1.2
—
9
71
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
24
218
1.12
0.15
3.4
2.7
ug/l
0.7
0.7
0.02
16
141
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
99
0.80
0.14
1.6
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
190
1.13
0.14
1.6
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
43
1.17
0.10
3.2
4.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
46
1.09
0.09
1.4
3.2
%
51.1
52.5
—
5
46
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
17
155
1.11
0.09
1.6
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
21
195
1.09
0.08
1.4
1.5
g/l
2.7
2.7
0.02
11
121
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
63
0.79
0.08
1.4
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
50
518
0.94
0.08
3.4
3.9
estimate
0.0
0.0
0.00
11
109
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
31
294
1.07
0.08
4.7
4.2
%
24.0
22.1
0.33
12
136
(3003694) ABO and Rh group [Type] in Blood
27
255
1.07
0.07
1.4
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
8
93
0.85
0.07
24.4
8.6
g/l
107.9
120.7
—
8
88
(21494755) Public health laboratory ask at order entry panel
9
103
0.86
0.06
1.1
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
110
0.90
0.05
1.5
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
11
119
0.92
0.04
2.3
1.6
%
1.5
1.4
0.21
11
102
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
29
298
0.97
0.02
1.4
1.6
mmol/l
1.6
1.5
0.25
24
251
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
103
1.07
0.02
1.9
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
103
1023
1.03
0.01
4.3
4.3
mmol/l
1.4
1.5
0.59
91
935
(3019832) Treponema pallidum Ab [Presence] in Serum
10
96
1.05
0.00
2.0
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
73
0.96
0.00
4.9
4.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
9.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
11.0
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
17.0
—
0
6
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
2.9
—
13.7
—
0
9
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
6.5
—
0
5
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
8
80
1.00
0.00
1.9
2.5
g/l
11.7
10.1
—
8
71
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
6
66
0.90
0.00
1.3
1.7
g/l
0.8
1.2
—
6
59
(40761536) Microorganisms panel - Urine sediment
9
98
0.91
0.00
5.7
3.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.1
—
2.9
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
72.0
—
0
5
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
90
1.00
0.00
1.0
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
9.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
52
0.96
0.00
21.8
7.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
10.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_FLOOROFMOUTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_FLOOROFMOUTH | 1.587 [1.24, 2.04] | < 0.001 |
| Birth year | 0.996 [0.99, 1.01] | 0.416 |
During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 431 females with CD2_BENIGN_FLOOROFMOUTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_FLOOROFMOUTH | 1.841 [1.37, 2.48] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.045 |
During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 342 males with CD2_BENIGN_FLOOROFMOUTH died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_FLOOROFMOUTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.164% | 0.368% |
| 5 | 0.817% | 2.139% |
| 10 | 2.325% | 5.75% |
| 15 | 4.773% | 10.59% |
| 20 | 8.665% | 17.4% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_FLOOROFMOUTH – Benign neoplasm: Floor of mouth
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data